Ergomed CRO Solutions Expo: Finding The Right Partner For Early-Stage Oncology Trials

Adam Jacobs, Executive Director and Strategic Consultant, Biostatistics at Ergomed, will explore how advanced statistical methodologies can improve dose-finding precision and decision-making in early-phase oncology trials. Moving beyond the traditional 3+3 design, he will demonstrate how adaptive and model-based approaches optimize dose escalation, streamline data interpretation, and support faster development timelines.